Treatment of bulimia with antidepressants. 1982

H G Pope, and J I Hudson

Bulimia is a syndrome of compulsive binge eating that is often associated with serious morbidity and usually resistant to existing psychological or pharmacological treatments. We report use of tricyclic antidepressants in eight bulimic patients, six of whom obtained moderate or marked reduction of their eating binges within 2-4 weeks. This preliminary observation suggests that antidepressants may be of value in treating bulimia and adds to the evidence linking bulimia with affective disorder.

UI MeSH Term Description Entries
D006963 Hyperphagia Ingestion of a greater than optimal quantity of food. Overeating,Polyphagia,Polyphagias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D000929 Antidepressive Agents, Tricyclic Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. Antidepressants, Tricyclic,Tricyclic Antidepressant,Tricyclic Antidepressant Drug,Tricyclic Antidepressive Agent,Tricyclic Antidepressive Agents,Antidepressant Drugs, Tricyclic,Agent, Tricyclic Antidepressive,Agents, Tricyclic Antidepressive,Antidepressant Drug, Tricyclic,Antidepressant, Tricyclic,Antidepressive Agent, Tricyclic,Drug, Tricyclic Antidepressant,Drugs, Tricyclic Antidepressant,Tricyclic Antidepressant Drugs,Tricyclic Antidepressants
D001068 Feeding and Eating Disorders A group of disorders characterized by physiological and psychological disturbances in appetite or food intake. Appetite Disorders,Eating Disorders,Eating and Feeding Disorders,Feeding Disorders,Appetite Disorder,Disorder, Eating,Disorder, Feeding,Disorders, Eating,Disorders, Feeding,Eating Disorder,Feeding Disorder

Related Publications

H G Pope, and J I Hudson
November 1989, DICP : the annals of pharmacotherapy,
H G Pope, and J I Hudson
January 1993, Psychopharmacology bulletin,
H G Pope, and J I Hudson
January 1987, Psychopharmacology bulletin,
H G Pope, and J I Hudson
March 1989, Clinical pediatrics,
H G Pope, and J I Hudson
March 1989, Clinical pediatrics,
H G Pope, and J I Hudson
January 2003, The Cochrane database of systematic reviews,
H G Pope, and J I Hudson
January 2001, The Cochrane database of systematic reviews,
H G Pope, and J I Hudson
April 2000, The Australian and New Zealand journal of psychiatry,
H G Pope, and J I Hudson
August 1989, Journal of clinical psychopharmacology,
H G Pope, and J I Hudson
October 1984, The American journal of psychiatry,
Copied contents to your clipboard!